Shares of Ryan Specialty Holdings Inc. (NYSE:RYAN – Get Free Report) have received a consensus recommendation of “Hold” from the nineteen research firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eight have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $52.03.
RYAN has been the subject of a number of recent research reports. JPMorgan Chase & Co. increased their price objective on shares of Ryan Specialty from $39.00 to $45.00 and gave the company an “underweight” rating in a report on Monday, August 3rd. Piper Sandler lowered their price target on Ryan Specialty from $48.00 to $40.00 and set a “neutral” rating for the company in a report on Tuesday, October 6th. Morgan Stanley boosted their price target on shares of Ryan Specialty from $48.00 to $50.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 19th. Keefe, Bruyette & Woods boosted their price objective on shares of Ryan Specialty from $48.00 to $54.00 and gave the company an “outperform” rating in a research report on Friday, July 31st. Finally, Atlantic Securities set a $69.00 price target on Ryan Specialty in a research report on Wednesday, July 15th.
View Our Latest Report on RYAN
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Covestor Ltd grew its position in Ryan Specialty by 64.2% in the third quarter. Covestor Ltd now owns 1,956 shares of the company’s stock valued at $72,000 after acquiring an additional 765 shares during the last quarter. Integrity Alliance LLC. bought a new position in shares of Ryan Specialty in the third quarter worth approximately $1,040,000. Gerber Kawasaki Wealth & Investment Management purchased a new stake in Ryan Specialty during the 3rd quarter valued at about $854,000. Vise Technologies Inc. increased its position in shares of Ryan Specialty by 189.0% during the third quarter. Vise Technologies Inc. now owns 24,941 shares of the company’s stock valued at $923,000 after buying an additional 16,311 shares during the period. Finally, Motley Fool Asset Management LLC purchased a new stake in shares of Ryan Specialty in the third quarter worth $3,952,000. Institutional investors own 84.82% of the company’s stock.
Ryan Specialty Stock Performance
Shares of Ryan Specialty stock opened at $43.83 on Friday. The business has a fifty day simple moving average of $40.42 and a two-hundred day simple moving average of $39.17. The company has a current ratio of 1.01, a quick ratio of 1.00 and a debt-to-equity ratio of 4.03. The firm has a market capitalization of $11.21 billion, a P/E ratio of 54.11, a P/E/G ratio of 0.90 and a beta of 0.54. Ryan Specialty has a 12 month low of $29.28 and a 12 month high of $58.94.
Ryan Specialty (NYSE:RYAN – Get Free Report) last issued its quarterly earnings data on Thursday, October 29th. The company reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.49 by $0.02. The business had revenue of $789.96 million for the quarter, compared to the consensus estimate of $792.99 million. Ryan Specialty had a return on equity of 47.77% and a net margin of 8.25%. During the same period in the prior year, the business posted $0.47 earnings per share. On average, equities analysts forecast that Ryan Specialty will post 2.17 earnings per share for the current fiscal year.
Ryan Specialty Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 24th. Investors of record on Tuesday, November 10th will be given a dividend of $0.13 per share. The ex-dividend date is Tuesday, November 10th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.2%. Ryan Specialty’s dividend payout ratio (DPR) is 64.20%.
Key Stories Impacting Ryan Specialty
Here are the key news stories impacting Ryan Specialty this week:
- Positive Sentiment: Q3 earnings exceeded expectations: Ryan Specialty reported adjusted EPS of $0.51, up from $0.47 a year earlier and above the $0.49 analyst consensus. Revenue increased 4.7% to approximately $790 million, while net income rose 40.6% to $88 million. Ryan Specialty Q3 earnings and revenue beat estimates
- Positive Sentiment: Capital returns remain supportive: The company returned $173.7 million to shareholders during the quarter, including $150 million in share repurchases. It also declared a quarterly dividend of $0.13 per share, equivalent to a $0.52 annualized payout and roughly a 1.2% yield.
- Positive Sentiment: RBC remains bullish: Royal Bank of Canada maintained an “outperform” rating, implying substantial upside from recent levels, although it reduced its price target from $55 to $52. RBC lowers Ryan Specialty price target
- Neutral Sentiment: Analyst sentiment is mixed: Ryan Specialty received a “hold” rating from a broader group of Wall Street analysts, balancing RBC’s positive view and the company’s earnings performance.
- Negative Sentiment: Organic growth slowed: Q3 organic revenue growth was 4%, raising concerns that expansion is moderating despite the earnings beat. The company maintained its full-year mid-single-digit organic growth outlook. Ryan Specialty organic growth slows to 4%
- Negative Sentiment: Profitability guidance softened: Management indicated that full-year adjusted EBITDAC margin could decline by roughly 50 basis points from the prior year, creating a headwind for valuation and future earnings growth.
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc is a specialty insurance services company that provides wholesale brokerage, managing general underwriting and delegated authority solutions. The company works with retail insurance brokers, agents, carriers and other market participants to place and manage complex, specialty risks that may require specialized underwriting expertise or customized coverage.
Its business includes specialty insurance and reinsurance brokerage, underwriting management and insurance program administration.
Recommended Stories
- Five stocks we like better than Ryan Specialty
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
